VANGUARD GROUP INC 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 09:51 am Sale | 2026-03-13 | 13G | INTELLIA THERAPEUTICS INC NTLA | VANGUARD GROUP INC | 0 0.000% | -13,010,001 (Position Closed) | Filing |
| 2026-01-30 2:16 pm Purchase | 2025-12-31 | 13G | INTELLIA THERAPEUTICS INC NTLA | VANGUARD GROUP INC | 13,010,001 11.230% | 2,820,048 (+27.67%) | Filing |
| 2025-01-08 11:29 am Purchase | 2024-12-31 | 13G | INTELLIA THERAPEUTICS INC NTLA | VANGUARD GROUP INC | 10,189,953 10.000% | 1,842,504 (+22.07%) | Filing |
| 2024-02-13 5:07 pm Purchase | 2023-12-29 | 13G | INTELLIA THERAPEUTICS INC NTLA | VANGUARD GROUP INC | 8,347,449 9.320% | 537,223 (+6.88%) | Filing |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | INTELLIA THERAPEUTICS INC NTLA | VANGUARD GROUP INC | 7,810,226 9.280% | 1,367,871 (+21.23%) | Filing |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | INTELLIA THERAPEUTICS INC NTLA | VANGUARD GROUP INC | 6,442,355 8.660% | 1,311,158 (+25.55%) | Filing |